DBV Technologies
DBVT
#7254
Rank
A$0.85 B
Marketcap
A$13.63
Share price
-0.47%
Change (1 day)
-43.69%
Change (1 year)

Earnings for DBV Technologies (DBVT)

Earnings in 2026 (TTM): -A$0.26 Billion

According to DBV Technologies's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.22 Billion a decrease over its 2024 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DBV Technologies from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.26 Billion22.65%
2025 -A$0.22 Billion28.68%
2024 -A$0.17 Billion56.58%
2023 -A$0.11 Billion-24.41%
2022 -A$0.14 Billion-2.02%
2021 -A$0.15 Billion-38.47%
2020 -A$0.23 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ionis Pharmaceuticals
IONS
-A$0.69 Billion 173.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-A$0.12 Billion-54.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.61 B-741.85%๐Ÿ‡บ๐Ÿ‡ธ USA